XNCR FY 2018 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$41M+13.7% YoY

Gross Profit

-$57M-140.1% margin

Operating Income

-$79M-195.5% margin

Net Income

-$70M-173.4% margin

EPS (Diluted)

$-1.31

Cash Flow

Operating Cash Flow

-$80M

Free Cash Flow

-$89M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$577M

Total Liabilities

$55M

Stockholders' Equity

$522M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$36M	+13.7%
Gross Profit	-$57M	-$36M	-57.8%
Operating Income	-$79M	-$54M	-48.2%
Net Income	-$70M	-$49M	-43.9%